ScholarLens Back to search
2019•Journal of the Medical Association of ThailandRequires access

Are 18-core Transrectal Ultrasound-guided Prostate Biopsies Feasible for Prostate Cancer Detection?

Sutthirat Sarawong, Charoen Leenanupunth, Suchin Worawichawong

Open publisher page 0 citations

Abstract

Objective: To determine the value of 18-core biopsies for prostate cancer detection. Materials and Methods: A cross sectional study was conducted. Men with abnormal PSA were enrolled. Every patient was subjected to 18-core TRUS biopsy. Parameters such as PSA, free PSA, prostate volume, PSA density and pathological results were recorded and compared between the 12-core group and 18-core group. Results: A total of 43 men with a mean age of 69.44 years was evaluated. The mean PSA was 99.09 ng/mL, mean Free PSA was 4.29 ng/ml, mean prostate volume was 56.50 ml and a mean PSAD was 2.31 ng/ml/ml. 13 were diagnosed with prostate cancer. The 18- sample biopsy procedures yielded a diagnosis of prostate cancer in 30.23% compared with 27.91% of patients on the basis of 12 biopsies and detected a higher Gleason score disease than those in the 12-core group. The 18-sample procedure improved the diagnosis yield by 7.69%. Significant differences in the Cancer detection core numbers were observed. No serious complications occurred. Conclusion: 18-core TRUS biopsy seemed to improve detection rates of prostate cancer and detected higher grade disease without causing any significant complications. Therefore, patients with suspected prostate cancer should be considered for 18 extended schemes. Keywords: 18-core transrectal ultrasound-guided prostate biopsies, Prostate cancer detection

About this research paper

What this paper is about

Objective: To determine the value of 18-core biopsies for prostate cancer detection. Materials and Methods: A cross sectional study was conducted. Men with abnormal PSA were enrolled. Every patient was subjected to 18-core TRUS biopsy. Parameters such as PSA, free PSA, prostate volume, PSA density and pathological results were recorded and compared between the 12-core group and 18-core group. Results: A total of 43 men with a mean age of 69.44 years was evaluated. The mean PSA was 99.09 ng/mL, mean Free PSA was 4.29 ng/ml, mean prostate volume was 56.50 ml and a mean PSAD was 2.31 ng/ml/ml. 13 were diagnosed with prostate cancer. The 18- sample biopsy procedures yielded a diagnosis of prostate cancer in 30.23% compared with 27.91% of patients on the basis of 12 biopsies and detected a higher Gleason score disease than those in the 12-core group. The 18-sample procedure improved the diagnosis yield by 7.69%. Significant differences in the Cancer detection core numbers were observed. No serious complications occurred. Conclusion: 18-core TRUS biopsy seemed to improve detection rates of prostate cancer and detected higher grade disease without causing any significant complications. Therefore, patients with suspected prostate cancer should be considered for 18 extended schemes. Keywords: 18-core transrectal ultrasound-guided prostate biopsies, Prostate cancer detection

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To determine the value of 18-core biopsies for prostate cancer detection. Materials and Methods: A cross sectional study was conducted. Men with abnormal PSA were enrolled. Every patient was subjected to 18-core TRUS biopsy. Parameters such as PSA, free PSA, prostate volume, PSA density and pathological results were recorded and compared between the 12-core group and 18-core group. Results: A total of 43 men with a mean age of 69.44 years was evaluated. The mean PSA was 99.09 ng/mL, mean Free PSA was 4.29 ng/ml, mean prostate volume was 56.50 ml and a mean PSAD was 2.31 ng/ml/ml. 13 were diagnosed with prostate cancer. The 18- sample biopsy procedures yielded a diagnosis of prostate cancer in 30.23% compared with 27.91% of patients on the basis of 12 biopsies and detected a higher Gleason score disease than those in the 12-core group. The 18-sample procedure improved the diagnosis yield by 7.69%. Significant differences in the Cancer detection core numbers were observed. No serious complications occurred. Conclusion: 18-core TRUS biopsy seemed to improve detection rates of prostate cancer and detected higher grade disease without causing any significant complications. Therefore, patients with suspected prostate cancer should be considered for 18 extended schemes. Keywords: 18-core transrectal ultrasound-guided prostate biopsies, Prostate cancer detection

Key concepts: Medicine, Prostate cancer, Prostate, Urology, Biopsy, Prostate biopsy, Cancer, Ultrasound

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Are 18-core Transrectal Ultrasound-guided Prostate Biopsies Feasible for Prostate Cancer Detection? — Research Paper | ScholarLens